Scarica l'app Stockscreener
1.96
2.62%
0.05
X T L Biopharmaceuticals Ltd Adr Borsa (XTLB) Ultime notizie
XTL Biopharmaceuticals (XTLB) Edges Higher as Shares Test $2.29 ResistanceRVOL Spike - https://www.dars.gov.et/
XTL Biopharmaceuticals (XTLB) Edges Higher as Shares Test $2.29 ResistanceIsland Reversal - siam.in
XTLB Stock Edges Higher: XTL Biopharmaceuticals ADR Ticks Up 0.46% to $2.17KAMA Signal - siam.in
XTL Biopharmaceuticals (XTLB) Trades Flat at $2.56, Sitting Midway Between Support and ResistanceFactor Rotation - siam.in
XTL Biopharmaceuticals (XTLB) Trades Flat at $2.56, Sitting Midway Between Support and ResistanceLiquidity Sweep - dars.gov.et
XTL Biopharmaceuticals (XTLB) Trades Flat at $2.56, Sitting Midway Between Support and ResistanceFibonacci Entry Signals - dars.gov.et
XTL Biopharmaceuticals (XTLB) Advances 4.2% to $2.48 as Clinical-Stage Biotech Draws Fresh Buying Interest - careplusvn.com
XTL Biopharmaceuticals (XTLB) Advances 4.2% to $2.48 as Clinical-Stage Biotech Draws Fresh Buying InterestBeta Neutral Pair - dars.gov.et
XTL Biopharmaceuticals (XTLB) Advances 4.2% to $2.48 as Clinical-Stage Biotech Draws Fresh Buying InterestIV Spike - www.dars.gov.et
XTL Biopharmaceuticals (XTLB) Advances 4.2% to $2.48 as Clinical-Stage Biotech Draws Fresh Buying InterestIV Crush Alert - https://www.dars.gov.et/
XCharge Announces Plan to Implement ADS Ratio Change - Yahoo Finance
XTL Biopharmaceuticals (XTLB) Slides 2.38% as Shares Approach Key Support at $2.73Max Pain Level - dars.gov.et
XTL Biopharmaceuticals (XTLB) Slips 7.67% to $2.65, Nears Key Support at $2.52ATR Stop - dars.gov.et
XTL Biopharmaceuticals Faces Derivative Action Bid Over Failed Social Proxy Acquisition - TipRanks
XTL Biopharmaceuticals Ltd. Sponsored ADR Revenue Breakdown – FWB:HHB0 - TradingView
XTL Biopharmaceuticals Regains Nasdaq Compliance and Enters One-Year Monitoring Period - The Globe and Mail
XTL Biopharmaceuticals Regains Nasdaq Compliance and Enters One-Year Monitoring Period - TipRanks
Enterprise value to EBITDA forward of XTL Biopharmaceuticals Ltd. Sponsored ADR – LSX:A41X7J - TradingView
XTL Biopharmaceuticals Completes Psyga Bio Acquisition, Refocuses on Psychedelic Medicine - TipRanks
XTL buys Psyga Bio, taking control of 83.4% of shares - Stock Titan
XTL Biopharmaceuticals Shareholders Approve Psyga Bio Acquisition and Major Capital Increase - TipRanks
Wondering what's happening in today's after-hours session? - ChartMill
XTL Biopharmaceuticals Adjourns Extraordinary Shareholder Meeting to June 29, 2026 - TipRanks
XTLB Stock Price, Quote & Chart - ChartMill
XTL Biopharmaceuticals (XTLB) Stock Price, News & Analysis $XTLB - MarketBeat
XTLB - Finviz
Wondering what's happening in today's after-hours session? - ChartMill
XTL Biopharmaceuticals Faces Added Nasdaq Delisting Risk Over Late 2025 Annual Report - TipRanks
XTL Biopharmaceuticals faces additional Nasdaq delisting risk - Investing.com
Eastern International Ltd. expands board, appoints two new directors - Investing.com
XTL Biopharmaceuticals Calls June 22, 2026 Meeting to Approve Psyga Bio Acquisition and Capital Raise - The Globe and Mail
XTL Biopharmaceuticals Calls June 22, 2026 Meeting to Approve Psyga Bio Acquisition and Capital Raise - TipRanks
SMX increases authorized shares for incentive plan and grants restricted stock units - Investing.com
XTL Biopharmaceuticals Wins Conditional Nasdaq Listing Reprieve Tied to Psyga Bio Deal - TipRanks
XTL Biopharmaceuticals Delays 20-F Amid Subsidiary Liquidation - TipRanks
U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.57% - Investing.com
XTL Biopharmaceuticals to Acquire PsygaBio in All-Stock Deal to Expand Psychedelic Drug Pipeline - TipRanks
XTL Biopharmaceuticals to acquire Psyga Bio for 40% stake - Investing.com
Double BottomStock ScreenerCharts - Finviz
Top GainersStock ScreenerSnapshot - Finviz
XTL Biopharmaceuticals Ltd ADR Each REPR 40 share price | XTLB - Hargreaves Lansdown
Debt to assets ratio of XTL Biopharmaceuticals Ltd. Sponsored ADR – GETTEX:HHB0 - TradingView
Total assets of XTL Biopharmaceuticals Ltd. Sponsored ADR – SWB:HHB0 - TradingView
Return on invested capital % of XTL Biopharmaceuticals Ltd. Sponsored ADR – SWB:HHB0 - TradingView
Free cash flow per share of XTL Biopharmaceuticals Ltd. Sponsored ADR – GETTEX:HHB0 - TradingView
Tangible book value per share of XTL Biopharmaceuticals Ltd. Sponsored ADR – SWB:HHB0 - TradingView
XTL Biopharmaceuticals Ltd. Sponsored ADR Trade Ideas — SWB:HHB0 - TradingView
Diluted earnings per share (diluted EPS) of XTL Biopharmaceuticals Ltd. Sponsored ADR – LS:A41X7J - TradingView
XTL Biopharmaceuticals Ltd. Sponsored ADR Cash Flow – LSX:A41X7J - TradingView
Average basic shares outstanding of XTL Biopharmaceuticals Ltd. Sponsored ADR – LSX:A41X7J - TradingView
4.22%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):